Table 1 Oxygenation and ventilation modalities preceding the initiation of Bag-CPAP
From: A new reservoir-based CPAP with low oxygen consumption: the Bag-CPAP
Device | Oxygen flow | Previous FiO2 (%) | SpO2 (%) | Etiology |
|---|---|---|---|---|
High concentration mask | 15 L/min | 90–100* | 100 | Acute cardiogenic pulmonary edema |
High concentration mask | 15 L/min | 90–100* | 91 | Acute cardiogenic pulmonary edema |
High concentration mask | 6 L/min | 60* | N/A | SARS-CoV-2 |
High concentration mask | 10 L/min | 80–90* | 95 | Acute decompensation of interstitial lung disease |
High concentration mask | 15 L/min | 90–100* | 86 | SARS-CoV-2 |
High concentration mask | 9 L/min | 80–90* | 98 | Acute decompensation of interstitial lung disease |
High concentration mask | 15 L/min | 90–100* | 84 | SARS-CoV-2 |
High concentration mask | 15 L/min | 90–100* | 95 | SARS-CoV-2 |
High concentration mask | 6 L/min | 60* | 96 | SARS-CoV-2 |
High concentration mask | 15 L/min | 90–100* | 92 | SARS-CoV-2 |
High concentration mask | 15 L/min | 90–100* | 91 | SARS-CoV-2 |
High concentration mask | 15 L/min | 90–100* | 94 | SARS-CoV-2 |
NIV | N/A | 60 | 99 | Acute cardiogenic pulmonary edema |
High concentration mask | 9 L/min | 80–90* | 97 | SARS-CoV-2 |
High concentration mask | 10 L/min | 80–90* | 90 | SARS-CoV-2 |
High concentration mask | 10 L/min | 80–90* | 93 | SARS-CoV-2 |
HFOT | N/A | 93 | 94 | SARS-CoV-2 |
HFOT | N/A | 100 | 88 | SARS-CoV-2 |
High concentration mask | 6 L/min | 60* | 98 | Acute cardiogenic pulmonary edema |
High concentration mask | 15 L/min | 90–100* | 86 | SARS-CoV-2 |